Skip to main content
. 2016 Apr 19;11(6):982–991. doi: 10.2215/CJN.06890615

Table 2.

Patient demographics and baseline characteristics (safety population)

Characteristic Cohort All Patients, n=145
A, n=24 B, n=24 C, n=24 D, n=24 E, n=24 F, n=25
Age, yr, mean (min, max) 65.9 (44, 83) 64.3 (32, 79) 59.2 (25, 78) 69.8 (48, 81) 61.8 (32, 78) 65.2 (41, 77) 64.4 (25, 83)
Men, n (%) 5 (20.8) 7 (29.2) 8 (33.3) 13 (54.2) 8 (33.3) 12 (48.0) 53 (36.6)
Weight, kg, mean (min, max) 89.9 (53, 139) 84.5 (55, 122) 89.5 (48, 138) 85.1 (48, 125) 88.3 (56, 140) 84.7 (48, 122) 87.0 (48, 140)
Race, n (%)
 White 17 (70.8) 14 (58.3) 14 (58.3) 17 (70.8) 14 (58.3) 17 (68.0) 93 (64.1)
 Black 7 (29.2) 7 (29.2) 9 (37.5) 5 (20.8) 7 (29.2) 7 (28.0) 42 (29.0)
 Other 0 3 (12.5) 1 (4.2) 2 (8.3) 3 (12.5) 1 (4.0) 10 (6.9)
Prevalence, n (%)
 Diabetes 16 (66.7) 17 (70.8) 18 (75.0) 15 (62.5) 13 (54.2) 12 (48.0) 91 (62.8)
 Hypertension 10 (41.7) 13 (54.2) 14 (58.3) 11 (45.8) 15 (62.5) 16 (64.0) 79 (54.5)
Hb, g/dl, mean (min, max) 9.6 (7.4,10.6) 9.7 (8.1, 10.5) 9.8 (8.8, 10.6) 9.7 (7.0, 10.6) 9.9 (8.6, 10.7) 9.7 (8.6, 10.5) 9.7 (7.0, 10.7)
Ferritin, ng/ml, mean (min, max) 322 (49, 1711) 282 (42, 744) 261 (33, 877) 283 (38, 1289) 207 (32, 803) 306 (37, 689) 277 (32, 1711)
 >100, n (%) 23 (95.8) 19 (79.2) 18 (75.0) 17 (70.8) 15 (62.5) 20 (80.0) 112 (77.2)
 ≤100, n (%) 1 (4.2) 5 (20.8) 6 (25.0) 7 (29.2) 9 (37.5) 5 (20.0) 33 (22.8)
TSAT, %, mean (min, max) 24.5 (9, 48) 19.9 (6, 41) 21.0 (12, 37) 24.4 (9, 41) 20.9 (12, 36) 21.5 (11, 39) 22.0 (6, 48)
 >20, n (%) 18 (75.0) 12 (50.0) 12 (50.0) 17 (70.8) 12 (50.0) 15 (60.0) 86 (59.3)
 ≤20, n (%) 6 (25.0) 12 (50.0) 12 (50.0) 7 (29.2) 12 (50.0) 10 (40.0) 59 (40.7)
Iron replete,a n (%) 18 (75.0) 11 (45.8) 11 (45.8) 14 (58.3) 9 (37.5) 13 (52.0) 76 (52.4)

min, max, minimum, maximum; Hb, hemoglobin; TSAT, transferrin saturation.

a

Iron replete is defined as TSAT>20% and ferritin >100 ng/ml.